Parkman Healthcare Partners LLC - Q2 2024 holdings

$747 Million is the total value of Parkman Healthcare Partners LLC's 90 reported holdings in Q2 2024. The portfolio turnover from Q1 2024 to Q2 2024 was 37.4% .

 Value Shares↓ Weighting
BSX BuyBOSTON SCIENTIFIC CORP$42,478,100
+45.8%
551,592
+29.6%
5.69%
+59.2%
PODD BuyINSULET CORP$36,183,749
+132.1%
179,305
+97.1%
4.85%
+153.4%
UTHR SellUNITED THERAPEUTICS CORP DEL$35,480,418
+20.5%
111,381
-13.1%
4.75%
+31.5%
LLY SellELI LILLY & CO$28,658,899
+14.7%
31,654
-1.4%
3.84%
+25.2%
BuyCOOPER COS INC$26,923,145
-7.0%
308,398
+8.1%
3.61%
+1.5%
THC SellTENET HEALTHCARE CORP$19,811,759
-33.6%
148,927
-47.5%
2.65%
-27.5%
AGIO NewAGIOS PHARMACEUTICALS INC$19,249,458446,416
+100.0%
2.58%
LBPH BuyLONGBOARD PHARMACEUTICALS IN$18,763,631
+25.3%
694,178
+0.1%
2.51%
+36.8%
SellRXSIGHT INC$17,854,786
-16.1%
296,739
-28.1%
2.39%
-8.4%
DXCM SellDEXCOM INC$17,784,220
-25.3%
156,855
-8.6%
2.38%
-18.5%
BDX BuyBECTON DICKINSON & CO$15,931,310
+41.2%
68,167
+49.5%
2.13%
+54.2%
NBIX SellNEUROCRINE BIOSCIENCES INC$15,855,454
-12.9%
115,170
-12.7%
2.12%
-4.9%
ANTM BuyELEVANCE HEALTH INC$15,037,157
+91.2%
27,751
+83.0%
2.01%
+108.7%
SDGR SellSCHRODINGER INC$13,951,354
-48.3%
721,373
-27.9%
1.87%
-43.6%
ABT BuyABBOTT LABS$12,667,980
-8.4%
121,913
+0.2%
1.70%0.0%
ITCI BuyINTRA-CELLULAR THERAPIES INC$12,672,568
+162.0%
185,028
+164.7%
1.70%
+186.2%
MNKD BuyMANNKIND CORP$12,578,107
+15.4%
2,409,599
+0.2%
1.68%
+26.0%
DAWN BuyDAY ONE BIOPHARMACEUTICALS I$12,523,567
+9.6%
908,822
+31.4%
1.68%
+19.6%
MRK NewMERCK & CO INCput$12,380,000100,000
+100.0%
1.66%
SNDX SellSYNDAX PHARMACEUTICALS INC$12,332,330
-34.0%
600,698
-23.5%
1.65%
-27.9%
NewKINIKSA PHARMACEUTICALS INTL$12,082,141647,142
+100.0%
1.62%
ICLR NewICON PLC$11,615,94437,056
+100.0%
1.56%
PCVX BuyVAXCYTE INC$11,340,922
+10.7%
150,191
+0.2%
1.52%
+20.8%
HUM NewHUMANA INC$11,223,32530,037
+100.0%
1.50%
BCYC BuyBICYCLE THERAPEUTICS PLCsponsored ads$10,829,675
-17.0%
535,063
+2.1%
1.45%
-9.4%
EWTX SellEDGEWISE THERAPEUTICS INC$10,347,051
-13.2%
574,517
-12.1%
1.39%
-5.3%
NRIX BuyNURIX THERAPEUTICS INC$9,906,551
+169.6%
474,679
+89.9%
1.33%
+194.2%
SellQIAGEN NV$9,626,031
-28.7%
234,267
-25.4%
1.29%
-22.2%
NARI BuyINARI MED INC$9,416,551
+56.6%
195,567
+56.0%
1.26%
+70.9%
KROS BuyKEROS THERAPEUTICS INC$9,077,254
-23.1%
198,627
+11.4%
1.22%
-16.1%
ATEC BuyALPHATEC HLDGS INC$8,907,747
+91.9%
852,416
+153.2%
1.19%
+109.3%
BuyARCELLX INC$8,656,165
-20.5%
156,843
+0.2%
1.16%
-13.2%
VRNA BuyVERONA PHARMA PLCsponsored ads$8,609,325
+1.0%
595,389
+12.4%
1.15%
+10.3%
GILD NewGILEAD SCIENCES INC$8,576,250125,000
+100.0%
1.15%
ABC SellCENCORA INC$8,564,554
-64.0%
38,014
-61.2%
1.15%
-60.7%
BMY NewBRISTOL-MYERS SQUIBB CO$8,306,000200,000
+100.0%
1.11%
XENE SellXENON PHARMACEUTICALS INC$8,160,217
-15.4%
209,290
-6.5%
1.09%
-7.6%
TVTX BuyTRAVERE THERAPEUTICS INC$7,972,512
+6.8%
969,892
+0.2%
1.07%
+16.6%
IONS BuyIONIS PHARMACEUTICALS INC$7,706,860
+25.6%
161,705
+14.3%
1.03%
+37.1%
ANAB NewANAPTYSBIO INC$6,423,053256,307
+100.0%
0.86%
RCUS BuyARCUS BIOSCIENCES INC$6,328,598
+29.0%
415,535
+59.9%
0.85%
+40.9%
CRNX BuyCRINETICS PHARMACEUTICALS IN$6,332,186
+33.8%
141,375
+39.8%
0.85%
+46.0%
HAE SellHAEMONETICS CORP MASS$6,294,016
-18.9%
76,079
-16.4%
0.84%
-11.5%
CSTL SellCASTLE BIOSCIENCES INC$6,049,774
-25.7%
277,895
-24.4%
0.81%
-18.9%
TEVA SellTEVA PHARMACEUTICAL INDS LTDsponsored ads$5,751,558
-10.1%
353,942
-22.0%
0.77%
-1.9%
IRWD BuyIRONWOOD PHARMACEUTICALS INC$5,713,267
-22.8%
876,268
+3.1%
0.76%
-15.7%
SLN BuySILENCE THERAPEUTICS PLCads$5,506,979
+4.3%
289,841
+18.6%
0.74%
+13.9%
INSM SellINSMED INC$5,378,157
+113.1%
80,271
-13.7%
0.72%
+132.3%
CVRX BuyCVRX INC$5,366,964
-11.3%
447,620
+34.8%
0.72%
-3.1%
APLT SellAPPLIED THERAPEUTICS INC$5,362,594
-57.5%
1,148,307
-38.1%
0.72%
-53.6%
NewAVADEL PHARMACEUTICALS PLC$5,318,743378,289
+100.0%
0.71%
STRO BuySUTRO BIOPHARMA INC$5,252,728
-48.1%
1,792,740
+0.2%
0.70%
-43.3%
FOLD BuyAMICUS THERAPEUTICS INC$4,984,433
+86.6%
502,463
+121.6%
0.67%
+103.7%
REPL NewREPLIMUNE GROUP INC$4,725,000525,000
+100.0%
0.63%
PFMT SellPERFORMANT FINL CORP$4,707,277
-3.5%
1,623,199
-2.2%
0.63%
+5.5%
LIVN SellLIVANOVA PLC$4,668,416
-42.4%
85,159
-41.3%
0.62%
-37.2%
URGN BuyUROGEN PHARMA LTD$4,605,523
+66.7%
274,465
+49.0%
0.62%
+82.0%
VCYT SellVERACYTE INC$4,539,323
-19.4%
209,475
-17.6%
0.61%
-12.0%
BuyMOONLAKE IMMUNOTHERAPEUTICSclass a ord$4,450,819
-12.3%
101,224
+0.2%
0.60%
-4.3%
CDMO BuyAVID BIOSERVICES INC$4,434,590
+145.0%
621,091
+129.9%
0.59%
+167.6%
RARE NewULTRAGENYX PHARMACEUTICAL IN$4,110,000100,000
+100.0%
0.55%
SellFORTREA HLDGS INC$3,565,628
-79.2%
152,769
-64.3%
0.48%
-77.3%
ARVN BuyARVINAS INC$3,331,786
-35.4%
125,161
+0.1%
0.45%
-29.5%
SellNUVALENT INC$3,253,484
-9.4%
42,888
-10.3%
0.44%
-0.9%
TGTX BuyTG THERAPEUTICS INC$3,207,893
+36.0%
180,320
+16.3%
0.43%
+48.8%
SellVENTYX BIOSCIENCES INC$2,679,651
-59.7%
1,160,022
-4.0%
0.36%
-56.0%
MRUS SellMERUS N V$2,671,644
-26.0%
45,152
-43.6%
0.36%
-19.2%
TERN NewTERNS PHARMACEUTICALS INC$2,657,739390,270
+100.0%
0.36%
SellNEWAMSTERDAM PHARMA COMPANYordinary shares$2,600,573
-45.1%
135,376
-32.4%
0.35%
-40.1%
ESPR BuyESPERION THERAPEUTICS INC NE$2,541,114
-17.0%
1,144,646
+0.2%
0.34%
-9.6%
BCRX NewBIOCRYST PHARMACEUTICALS INC$2,474,769400,448
+100.0%
0.33%
DVAX SellDYNAVAX TECHNOLOGIES CORP$2,434,911
-26.4%
216,822
-18.6%
0.33%
-19.7%
QTRX BuyQUANTERIX CORP$2,329,940
-43.8%
176,377
+0.2%
0.31%
-38.7%
SIBN BuySI-BONE INC$1,978,484
-20.9%
153,015
+0.2%
0.26%
-13.7%
ELAN SellELANCO ANIMAL HEALTH INC$1,818,786
-44.5%
126,042
-37.3%
0.24%
-39.3%
BuyTHIRD HARMONIC BIO INC$1,733,225
+359.0%
133,325
+233.3%
0.23%
+404.3%
ANNX SellANNEXON INC$1,601,541
-35.6%
326,845
-5.7%
0.22%
-29.5%
EPIX BuyESSA PHARMA INC$1,325,899
-38.0%
252,072
+0.1%
0.18%
-32.1%
ARDX SellARDELYX INC$1,112,923
-23.8%
150,192
-24.9%
0.15%
-16.8%
VKTX SellVIKING THERAPEUTICS INC$1,079,920
-56.5%
20,372
-32.8%
0.14%
-52.5%
AKYA SellAKOYA BIOSCIENCES INC$878,754
-79.6%
375,536
-59.1%
0.12%
-77.7%
ETON BuyETON PHARMACEUTICALS INC$833,018
+11.5%
253,197
+27.1%
0.11%
+21.7%
ENTX NewENTERA BIO LTD$738,793401,518
+100.0%
0.10%
SellVYNE THERAPEUTICS INC$680,056
-68.2%
345,206
-50.4%
0.09%
-65.3%
RVPH BuyREVIVA PHARMACEUTCLS HLDGS I$645,888
-66.1%
504,600
+0.1%
0.09%
-62.8%
AUGX SellAUGMEDIX INC$498,824
-88.6%
566,845
-46.8%
0.07%
-87.5%
XFOR BuyX4 PHARMACEUTICALS INC$467,837
-58.2%
806,616
+0.2%
0.06%
-54.0%
TELA BuyTELA BIO INC$459,735
-17.0%
97,816
+0.2%
0.06%
-8.8%
TKNO BuyALPHA TEKNOVA INC$406,413
-48.2%
296,652
+0.2%
0.05%
-43.8%
BuyXERIS BIOPHARMA HOLDINGS INC$226,868
+2.0%
100,830
+0.2%
0.03%
+11.1%
NVCR ExitNOVOCURE LTD$0-50,000
-100.0%
-0.10%
BFLY ExitBUTTERFLY NETWORK INC$0-750,000
-100.0%
-0.10%
ExitSOPHIA GENETICS SAordinary shares$0-209,896
-100.0%
-0.13%
CYTK ExitCYTOKINETICS INC$0-20,160
-100.0%
-0.17%
INZY ExitINOZYME PHARMA INC$0-222,943
-100.0%
-0.21%
ETNB Exit89BIO INC$0-179,899
-100.0%
-0.26%
ABOS ExitACUMEN PHARMACEUTICALS INC$0-576,657
-100.0%
-0.29%
NKTX ExitNKARTA INC$0-252,028
-100.0%
-0.33%
IDYA ExitIDEAYA BIOSCIENCES INC$0-66,332
-100.0%
-0.36%
CGEM ExitCULLINAN ONCOLOGY INC$0-178,396
-100.0%
-0.37%
LYRA ExitLYRA THERAPEUTICS INC$0-642,245
-100.0%
-0.49%
CNC ExitCENTENE CORP DEL$0-55,794
-100.0%
-0.54%
FLDM ExitSTANDARD BIOTOOLS INC$0-1,670,401
-100.0%
-0.56%
CRL ExitCHARLES RIV LABS INTL INC$0-17,697
-100.0%
-0.59%
AVDL ExitAVADEL PHARMACEUTICALS PLCsponsored adr$0-387,770
-100.0%
-0.80%
ExitDISC MEDICINE INC$0-107,593
-100.0%
-0.82%
TMO ExitTHERMO FISHER SCIENTIFIC INC$0-15,572
-100.0%
-1.11%
DCPH ExitDECIPHERA PHARMACEUTICALS IN$0-729,230
-100.0%
-1.41%
HCA ExitHCA HEALTHCARE INC$0-35,283
-100.0%
-1.44%
OSCR ExitOSCAR HEALTH INCcl a$0-831,283
-100.0%
-1.52%
KNSA ExitKINIKSA PHARMACEUTICALS LTD$0-646,163
-100.0%
-1.56%
SILK ExitSILK RD MED INC$0-848,897
-100.0%
-1.91%
INSP ExitINSPIRE MED SYS INC$0-81,183
-100.0%
-2.14%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2024-08-14
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
DEXCOM INC19Q2 20246.3%
XENON PHARMACEUTICALS INC19Q2 20243.3%
SCHRODINGER INC18Q2 20244.2%
MANNKIND CORP18Q2 20241.7%
INSULET CORP17Q2 20244.8%
AVID BIOSERVICES INC17Q2 20242.9%
ARCUS BIOSCIENCES INC17Q2 20242.1%
ACLARIS THERAPEUTICS INC16Q3 202310.0%
NATERA INC16Q3 20233.4%
SUTRO BIOPHARMA INC16Q2 20241.9%

View Parkman Healthcare Partners LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Parkman Healthcare Partners LLC Q2 2024 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
PLUS THERAPEUTICS, INC.February 13, 2023583,4671.7%

View Parkman Healthcare Partners LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-08-14
N-PX2024-08-01
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-11
13F-HR2023-05-12
SC 13G/A2023-02-13
13F-HR2023-02-13
13F-HR2022-11-14

View Parkman Healthcare Partners LLC's complete filings history.

Compare quarters

Export Parkman Healthcare Partners LLC's holdings